Some Issues andTheir Solutions in the Process Developmentof Ethyl 2‑(4-Aminophenoxy)thiazole-5-carboxylate: A Key Intermediateof P2X₃ Antagonist

Ethyl 2-(4-aminophenoxy)thiazole-5-carboxylate is a key intermediate of several P2X₃ antagonists required for clinical trials. The synthesis at the early R&D stage delivered this thiazole derivative via a nucleophilic aromatic substitution reaction in highly variable yields, from 7 to 85%. We describe the process development of the initial route of synthesis carefully considering the reaction conditions, process robustness and safety, operational improvement, and the impact on downstream steps. The optimized process was successfully replicated on a multikg scale in a pilot plant, allowing for the supply of the key intermediate in 90% isolated yield with high purity (>99 area%).